Given the importance of tumor-intrinsic IFNγ signaling in sensitizing KPAR tumors to antitumor immune responses, the ability of oncogenic KRAS to suppress IFN pathway signaling may represent a major mechanism of immune evasion in KRAS-mutant lung adenocarcinoma. This evidence concerns the gene IFNG and neoplasm.